(0.02%) 5 470.28 points
(0.15%) 39 169 points
(0.28%) 17 767 points
(0.09%) $80.90
(-5.04%) $2.62
(-0.83%) $2 311.50
(-0.17%) $28.82
(3.22%) $1 018.20
(0.33%) $0.936
(0.75%) $10.68
(0.49%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies...
Stats | |
---|---|
Dagens volum | 510 373 |
Gjennomsnittsvolum | 810 653 |
Markedsverdi | 396.27M |
EPS | $-0.0952 ( Q1 | 2024-03-31 ) |
Neste inntjeningsdato | ( $-0.0800 ) 2024-08-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-4.03 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00300 (0.19%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-31 | Shah Rutul R | Buy | 550 000 | Option to Purchase Common Stock (Right to Buy) |
2024-05-31 | Perez Jeffrey Thomas | Buy | 300 000 | Option to Purchase Common Stock (Right to Buy) |
2024-05-31 | Sabzevari Helen | Buy | 1 803 000 | Option to Purchase Common Stock (Right to Buy) |
2024-05-31 | Thomasian Harry Jr. | Buy | 500 000 | Option to Purchase Common Stock (Right to Buy) |
2024-05-31 | Lehr Donald P. | Buy | 400 000 | Option to Purchase Common Stock (Right to Buy) |
INSIDER POWER |
---|
71.97 |
Last 100 transactions |
Buy: 25 508 369 | Sell: 4 433 991 |
Volum Korrelasjon
Precigen Inc Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Precigen Inc Korrelasjon - Valuta/Råvare
Precigen Inc Økonomi
Annual | 2023 |
Omsetning: | $6.23M |
Bruttogevinst: | $-4.74M (-76.18 %) |
EPS: | $-0.390 |
FY | 2023 |
Omsetning: | $6.23M |
Bruttogevinst: | $-4.74M (-76.18 %) |
EPS: | $-0.390 |
FY | 2022 |
Omsetning: | $26.91M |
Bruttogevinst: | $20.57M (76.44 %) |
EPS: | $-0.400 |
FY | 2021 |
Omsetning: | $103.87M |
Bruttogevinst: | $45.49M (43.79 %) |
EPS: | $-0.470 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Precigen Inc
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.